Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

14 June 2021: Lab/In Vitro Research

Helenalin Facilitates Reactive Oxygen Species-Mediated Apoptosis and Cell Cycle Arrest by Targeting Thioredoxin Reductase-1 in Human Prostate Cancer Cells

Mei Yang 1A , Weihua Zhang 2B , Xiuxiu Yu 3C , Feng Wang 3D , Yeping Li 3E , Yan Zhang 3F , Yu Yang 3AG*

DOI: 10.12659/MSM.930083

Med Sci Monit 2021; 27:e930083

Figure 6 Helenalin treatment induces apoptosis and cell cycle arrest through suppressing TrxR1 expression for prostate carcinoma cells. (A–D) Apoptotic levels were examined in 2 prostate carcinoma cells exposed to si-TrxR1, TrxR1 plasmid and/or helenalin by flow cytometry. **** P<0.0001. (E–H) Cell cycle was evaluated in the 2 prostate cancer cells following treatment with si-TrxR1, TrxR1 plasmid, and/or helenalin by flow cytometry. Compared to si-NC, **** P<0.0001. Compared to si-TrxR1, # P<0.05 and #### P<0.0001. Compared to empty vector, &&&& P<0.0001. Compared to TrxR1, @@@@ P<0.0001.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750